Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-21

FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Pentazocine and Naloxone from Actavis Pharma, authorizing a generic pentazocine/naloxone combination analgesic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentazocine and Naloxone (Pentazocine hydrochloride and naloxone hydrochloride)

Snippet

SUPPL AP for PENTAZOCINE AND NALOXONE (PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE)